Vineet Laboratories [VINEETLAB] vs Nippon Life India [NAM] Detailed Stock Comparison

Vineet Laboratories
NSE
Loading...

Nippon Life India
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Vineet Laboratories wins in 7 metrics, Nippon Life India wins in 10 metrics, with 0 ties. Nippon Life India appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Vineet Laboratories | Nippon Life India | Better |
---|---|---|---|
P/E Ratio (TTM) | 316.25 | 151.53 | Nippon Life India |
Price-to-Book Ratio | 2.30 | 4.76 | Vineet Laboratories |
Debt-to-Equity Ratio | 285.88 | 0.00 | Nippon Life India |
PEG Ratio | -5.33 | N/A | N/A |
EV/EBITDA | -5.22 | 74.06 | Vineet Laboratories |
Profit Margin (TTM) | -31.44% | 0.49% | Nippon Life India |
Operating Margin (TTM) | -3.88% | 1.65% | Nippon Life India |
EBITDA Margin (TTM) | N/A | 1.65% | N/A |
Return on Equity | -81.56% | 3.14% | Nippon Life India |
Return on Assets (TTM) | -10.05% | 3.01% | Nippon Life India |
Free Cash Flow (TTM) | $104.46M | $-8.13M | Vineet Laboratories |
1-Year Return | -41.92% | -33.99% | Nippon Life India |
Price-to-Sales Ratio (TTM) | 0.53 | 1.12 | Vineet Laboratories |
Enterprise Value | $706.65M | $474.79M | Vineet Laboratories |
EV/Revenue Ratio | 1.17 | 0.97 | Nippon Life India |
Gross Profit Margin (TTM) | 38.03% | -21.63% | Vineet Laboratories |
Revenue per Share (TTM) | $65 | $90 | Nippon Life India |
Earnings per Share (Diluted) | $-20.53 | $0.66 | Nippon Life India |
Beta (Stock Volatility) | -0.27 | 0.77 | Vineet Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vineet Laboratories vs Nippon Life India Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Vineet Laboratories | 0.78% | 3.58% | 7.69% | 15.96% | -18.43% | -41.07% |
Nippon Life India | -0.51% | 7.57% | 31.96% | 16.29% | -1.47% | -28.05% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Vineet Laboratories | -41.92% | -40.74% | -35.52% | -35.52% | -35.52% | -35.52% |
Nippon Life India | -33.99% | 143.93% | 176.27% | 439.14% | 497.07% | 497.07% |
Performance & Financial Health Analysis: Vineet Laboratories vs Nippon Life India
Metric | VINEETLAB | NAM |
---|---|---|
Market Information | ||
Market Cap | ₹317.41M | ₹544.59M |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 41,307 | 212 |
90 Day Avg. Volume | 31,822 | 138 |
Last Close | ₹34.70 | ₹99.50 |
52 Week Range | ₹26.51 - ₹64.89 | ₹68.64 - ₹198.00 |
% from 52W High | -46.52% | -49.75% |
All-Time High | ₹124.00 (Jul 12, 2021) | ₹198.00 (Sep 02, 2024) |
% from All-Time High | -72.02% | -49.75% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.69% | -0.60% |
Quarterly Earnings Growth | -0.69% | -0.43% |
Financial Health | ||
Profit Margin (TTM) | -0.31% | 0.00% |
Operating Margin (TTM) | -0.04% | 0.02% |
Return on Equity (TTM) | -0.82% | 0.03% |
Debt to Equity (MRQ) | 285.88 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹15.00 | ₹21.01 |
Cash per Share (MRQ) | ₹0.62 | ₹11.69 |
Operating Cash Flow (TTM) | ₹76.58M | ₹16.34M |
Levered Free Cash Flow (TTM) | ₹-201,910,000 | ₹3.57M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Vineet Laboratories vs Nippon Life India
Metric | VINEETLAB | NAM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 316.25 | 151.53 |
Forward P/E | N/A | N/A |
PEG Ratio | -5.33 | N/A |
Price to Sales (TTM) | 0.53 | 1.12 |
Price to Book (MRQ) | 2.30 | 4.76 |
Market Capitalization | ||
Market Capitalization | ₹317.41M | ₹544.59M |
Enterprise Value | ₹706.65M | ₹474.79M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.17 | 0.97 |
Enterprise to EBITDA | -5.22 | 74.06 |
Risk & Other Metrics | ||
Beta | -0.27 | 0.77 |
Book Value per Share (MRQ) | ₹15.00 | ₹21.01 |
Financial Statements Comparison: Vineet Laboratories vs Nippon Life India
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | VINEETLAB | NAM |
---|---|---|
Revenue/Sales | ₹74.42M | ₹45.43M |
Cost of Goods Sold | ₹46.12M | ₹55.25M |
Gross Profit | ₹28.30M | ₹-9.83M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-3.08M | ₹-13.11M |
EBITDA | ₹3.36M | ₹-1.57M |
Pre-Tax Income | ₹-9.02M | ₹-2.17M |
Income Tax | ₹-355,000 | ₹-297,000 |
Net Income (Profit) | ₹-8.66M | ₹-1.87M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | VINEETLAB | NAM |
---|---|---|
Cash & Equivalents | ₹3.07M | ₹1.50M |
Total Current Assets | ₹673.94M | ₹94.28M |
Total Current Liabilities | ₹743.89M | ₹3.96M |
Long-Term Debt | ₹37.86M | ₹0 |
Total Shareholders Equity | ₹146.48M | ₹113.51M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | N/A | ₹24.14M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | VINEETLAB | NAM |
---|---|---|
Operating Cash Flow | ₹-59.92M | N/A |
Capital Expenditures | ₹0 | N/A |
Free Cash Flow | ₹154.67M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | VINEETLAB | NAM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 41,307 | 212 |
Average Daily Volume (90 Day) | 31,822 | 138 |
Shares Outstanding | 9.22M | 5.39M |
Float Shares | 5.56M | 484,473 |
% Held by Insiders | 0.34% | 0.87% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Vineet Laboratories vs Nippon Life India
Metric | VINEETLAB | NAM |
---|---|---|
Last 12-Month Dividend | ₹0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | ₹0.33 | N/A |
3-Year Avg Dividend Yield | 1.64% | N/A |
3-Year Total Dividends | ₹1.00 | N/A |
Ex-Dividend Date | Sep 19, 2022 | N/A |